SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
Eva Anna Marianne Baerends(Aarhus University), M. Ruwald(Aarhus University), Henrik Nielsen(Aalborg University Hospital), Lothar Wiese(Zealand University Hospital), Palle Valentiner‐Branth(Statens Serum Institut), Britta Tarp, Lone Wulff Madsen(University of Southern Denmark), Martin Tolstrup(Aarhus University), S. Schieber, L. Krohn-Dehli, Nina Breinholt Stærke(Aarhus University), Işık Somuncu Johansen, Susan Olaf Lindvig(Odense University Hospital), Ole S. Søgaard(Aarhus University Hospital), Astrid Korning Hvidt(Aarhus University), E. Højmark, Y. Yehdego, Marianne Hoegsbjerg Schleimann, Kristine Toft Petersen(Aalborg University Hospital), Vibeke Klastrup(Aarhus University), Joanne Reekie(University of Copenhagen), Mette Brouw Iversen(Zealand University Hospital), Thea Kølsen Fischer, K.T. Petersen(Aalborg University Hospital), Przemys aw Wyr bek, Christian Erikstrup(Aarhus University Hospital), Henrik Nielsen(Aalborg University Hospital), Kamille Fogh(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Kasper Iversen(University of Copenhagen), D. K. Petersen(Aalborg University Hospital), Lisa Loksø Dietz(Aarhus University), Thomas Benfield(University of Copenhagen), Anna Karina Juhl(Aarhus University), Lars Østergaard(Aarhus University), Dorthe Raben(University of Copenhagen), Jacob Bodilsen(Aalborg University Hospital), M. Tousgaard(Aarhus University), S.H. Rasmussen, Maria Ruwald Juhl(Aalborg University Hospital), F Larsen, Lene Surland Knudsen(Zealand University Hospital), Signe Rode Andreasen(Aarhus University), Sidsel Dahl Andersen(Aarhus University), A. Søndergaard
Cited by 26